Control,human serum

Closed Solicitation Posted

Solicitation number
SPE2DS27T0992
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
Not on record

Notice details come from DLA DIBBS. Updated .

About this opportunity

The Defense Logistics Agency Troop Support Medical seeks quotes for five units (six packages each) of CONTROL,HUMAN SERUM, NSN 6550-01-627-2275, under request for quotation SPE2DS27T0992, with quotes due November 2, 2026. The Set Aside line reads "No Set-Aside Used." Quotes must be submitted through DIBBS.

Delivery is due within 20 days to USNS Comfort (TAH-20) in FPO AE, on FOB Destination terms with inspection at destination. The GovTribe summary identifies the item as Abbott Laboratories I-STAT CK-MB Control Level 1, a human serum-based in vitro diagnostic control for measuring creatine kinase MB mass in whole blood or plasma. The product must be refrigerated at 2-8 degrees Celsius and carry a 12-month non-extendable shelf life, with no more than one month elapsed from manufacture to delivery. Compliance is required with FDA Class I regulation 862.1660, medical marking standards, and DLA packaging requirements. The solicitation also requires Buy American Act compliance, transportation of supplies by sea, hazardous material identification, safeguarding of defense information, and compliance with covered defense telecommunications equipment restrictions. Quotes must include all required representations and certifications in SAM.

The solicitation is a Fast Auto Evaluation issued under the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026), posted October 27, 2026, and classified under PSC 6550. Automated awards are possible except where first article test requirements apply. Fast Pay applies if the final award value does not exceed the FAR 13.402(a) threshold. The buyer may combine requirements or reduce quantity without resolicitation, and offerors are strongly encouraged to submit quantity ranges.

Notice text

DLA request for quotation SPE2DS27T0992, issued by DLA office SPE2DS through DIBBS. Quotes are due by 11/02/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, CONTROL,HUMAN SERUM, NSN 6550-01-627-2275, 5 PG, delivery in 20 days, PR 7018375545. Quotes must be submitted via DIBBS.

Files

File Type Posted
SPE2DS27T0992.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Control,blood chemist Medical Supply Chain No set-aside
Control,hemoglobin Medical Supply Chain No set-aside
Control kit,blood GRO Medical Supply Chain No set-aside
Control set,human SER Medical Supply Chain No set-aside
Control set,blood CHE Medical Supply Chain No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors